Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma

por Lièvre, A, Blons, H, Houllier, A M, Laccourreye, O, Brasnu, D, Beaune, P, Laurent-Puig, P
Publicado 2006

Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma

por Onda, T, Uzawa, K, Endo, Y, Bukawa, H, Yokoe, H, Shibahara, T, Tanzawa, H
Publicado 2006

A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours

por Yen, W-C, Prudente, R Y, Corpuz, M R, Negro-Vilar, A, Lamph, W W
Publicado 2006

Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours

por Wang, Y, Hewitt, S M, Liu, S, Zhou, X, Zhu, H, Zhou, C, Zhang, G, Quan, L, Bai, J, Xu, N
Publicado 2006

CCL19 reduces tumour burden in a model of advanced lung cancer

por Hillinger, S, Yang, S-C, Batra, R K, Strieter, R M, Weder, W, Dubinett, S M, Sharma, S
Publicado 2006

Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study

por Klautke, G, Küchenmeister, U, Foitzik, T, Ludwig, K, Prall, F, Klar, E, Fietkau, R
Publicado 2006

A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

por Park, Y H, Kim, B-S, Ryoo, B-Y, Yang, S H
Publicado 2006

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

por Seshadri, T, Gook, D, Lade, S, Spencer, A, Grigg, A, Tiedemann, K, McKendrick, J, Mitchell, P, Stern, C, Seymour, J F
Publicado 2006

Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up

por Korfage, I J, Essink-Bot, M-L, Janssens, A C J W, Schröder, F H, de Koning, H J
Publicado 2006

A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia

por Scott, I S, Odell, E, Chatrath, P, Morris, L S, Davies, R J, Vowler, S L, Laskey, R A, Coleman, N
Publicado 2006

Net1 and Myeov: computationally identified mediators of gastric cancer

por Leyden, J, Murray, D, Moss, A, Arumuguma, M, Doyle, E, McEntee, G, O'Keane, C, Doran, P, MacMathuna, P
Publicado 2006

TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells

por Cantarella, G, Risuglia, N, Dell'eva, R, Lempereur, L, Albini, A, Pennisi, G, Scoto, G M, Noonan, D N, Bernardini, R
Publicado 2006

ATM haplotypes and breast cancer risk in Jewish high-risk women

por Koren, M, Kimmel, G, Ben-Asher, E, Gal, I, Papa, M Z, Beckmann, J S, Lancet, D, Shamir, R, Friedman, E
Publicado 2006

Malignant melanoma and bone resorption

por Lau, Y S, Sabokbar, A, Giele, H, Cerundolo, V, Hofstetter, W, Athanasou, N A
Publicado 2006

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

por Iehara, T, Hosoi, H, Akazawa, K, Matsumoto, Y, Yamamoto, K, Suita, S, Tajiri, T, Kusafuka, T, Hiyama, E, Kaneko, M, Sasaki, F, Sugimoto, T, Sawada, T
Publicado 2006

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

por Andersen, J B, Aaboe, M, Borden, E C, Goloubeva, O G, Hassel, B A, Ørntoft, T F
Publicado 2006

A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging

por Morgan, B, Utting, J F, Higginson, A, Thomas, A L, Steward, W P, Horsfield, M A
Publicado 2006

Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer

por Zhu, C-Q, Cutz, J-C, Liu, N, Lau, D, Shepherd, F A, Squire, J A, Tsao, M-S
Publicado 2006

Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer

por Baek, J H, Kim, J G, Jeon, S B, Chae, Y S, Kim, D H, Sohn, S K, Lee, K B, Choi, Y J, Shin, H J, Chung, J S, Cho, G J, Jung, H Y, Yu, W
Publicado 2006

Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer

por Nakamura, K, Yamaguchi, T, Ishihara, T, Sudo, K, Kato, H, Saisho, H
Publicado 2006